For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and the formulated version represents a genuine advancement . These groundbreaking therapies stabilize the transthyretin protein, halting its damaging build-up and alleviating